Litcius/Paper detail

The cut-off value for HOMA-IR discriminating the insulin resistance based on the SHBG level in women with polycystic ovary syndrome

Aleksandra Biernacka-Bartnik, Piotr Kocełak, Aleksander Owczarek, Piotr Choręża, Leszek Markuszewski, Paweł Madej, Monika Puzianowska‐Kuźnicka, Jerzy Chudek, Magdalena Olszanecka‐Glinianowicz

2023Frontiers in Medicine32 citationsDOIOpen Access PDF

Abstract

Introduction: The study aimed to estimate the cut-off value for homeostatic model assessment for insulin resistance (HOMA-IR) discriminating the insulin resistance based on the sex hormones binding globulin (SHBG) level in women with polycystic ovary syndrome (PCOS). Materials and methods: Data from medical records of 854 Caucasian women diagnosed with PCOS were analyzed. Anthropometric data, fasting plasma glucose, insulin and SHBG levels were measured. HOMA-IR was calculated with a standard formula. The cut-off value was calculated using receiver-operating characteristics. Results: Circulating SHBG levels below the normal range (26.1 nmol/L) were found in 25.4% of study participants. This subgroup had a significantly higher BMI, fasting glucose and insulin concentrations and HOMA-IR values. Empirical optimal cut-off values for HOMA-IR corresponding to low SHBG levels was ≥2.1 [area under the curve (AUC) 0.73, accuracy 0.65, sensitivity 72.3%, specificity 63.1%, positive predictive value (PPV) 40.0%, negative predictive value (NPV) 87.0%]. Conclusions: Our study suggests that the cut-off point for HOMA-IR discriminating the insulin resistance based on the SHBG level, in young Caucasian women with polycystic ovary syndrome is 2.1, and is consistent with the cut-off value adopted by the European Group for the Study of Insulin Resistance (above 2.0).

Topics & Concepts

Polycystic ovaryInsulin resistanceSex hormone-binding globulinInternal medicineEndocrinologyMedicineInsulinHomeostatic model assessmentHormoneAndrogenOvarian function and disordersHormonal and reproductive studiesDiabetes, Cardiovascular Risks, and Lipoproteins